Drug repurposing to treat asthma and allergic disorders: Progress and prospects
Author:
Affiliation:
1. Medical Scientist Training Program; Baylor College of Medicine; Houston TX USA
2. Division of Allergy & Immunology; Department of Pediatrics; Emory University School of Medicine; Atlanta GA USA
Publisher
Wiley
Subject
Immunology,Immunology and Allergy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/all.13305/fullpdf
Reference100 articles.
1. Trends in allergic conditions among children: United States, 1997-2011;Jackson;NCHS Data Brief,2013
2. The increase in allergy and extended challenges;Linneberg;Allergy,2011
3. Antihistamines: do they work? Further well-controlled trials involving larger samples are needed;Fumagalli;Allergy,2004
4. Refractory asthma: mechanisms, targets, and therapy;Trevor;Allergy,2014
5. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma;Busse;J Allergy Clin Immunol,2001
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Novel Immunopharmacological Drugs for the Treatment of Allergic Diseases;Annual Review of Pharmacology and Toxicology;2024-01-23
2. Epigenome-wide DNA methylation association study of circulating IgE levels identifies novel targets for asthma;eBioMedicine;2023-09
3. Pathogenesis of allergic diseases and implications for therapeutic interventions;Signal Transduction and Targeted Therapy;2023-03-24
4. Anti-Allergic Properties of Propolis: Evidence From Preclinical and Clinical Studies;Frontiers in Pharmacology;2022-01-21
5. Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Dissecting New Mechanism of Action Through In Vitro and In Vivo Analyses;Frontiers in Oncology;2021-10-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3